Inquiries on NovaStem continue at the COA Annual Meeting in China / Photo provided by REV-MED
[BigDataNews | Reporter Byunghak Lee]
Global leader in regenerative medicine, REV-MED (CEO Edward BG Shin), successfully concluded its participation as an exhibitor at the Chinese Orthopaedic Association (COA) Annual Meeting.
Held from December 4 to 8 in Wuhan, Hubei Province, the event is a large-scale international conference attended by healthcare professionals from China and abroad. It serves as a platform for sharing cutting-edge trends and new paradigms among medical specialists, university professors, and medical device professionals.
The COA Annual Meeting contributes significantly to the development of China’s medical industry by offering specialized academic lectures, showcasing the latest technologies and equipment, and fostering collaboration between physicians, researchers, hospitals, and businesses. The conference has been steadily expanding, featuring international orthopedic experts who share their expertise and insights.
At the exhibition, REV-MED showcased its flagship export products, including NovaStem, TriCell, and PRP UNI—kits designed to extract and concentrate key beneficial cells from bone marrow and blood. Its patented Three-Chamber system minimizes manipulation and blocks red blood cells that can trigger inflammation, enabling safe and high-concentration preparation of biologics for a wide range of clinical applications.
A REV-MED representative stated,
“Through our participation in the COA Annual Meeting, we were able to present our technological capabilities to stakeholders from China and abroad. We will continue to strengthen our position as a global leader in regenerative medicine.”
Meanwhile, in 2024, REV-MED has participated in 26 domestic and international academic conferences and exhibitions, actively promoting the excellence of its products.
Reporter Byunghak Lee | lbh@thebigdata.co.kr
Source: BigDataNews
Inquiries on NovaStem continue at the COA Annual Meeting in China / Photo provided by REV-MED
[BigDataNews | Reporter Byunghak Lee]
Global leader in regenerative medicine, REV-MED (CEO Edward BG Shin), successfully concluded its participation as an exhibitor at the Chinese Orthopaedic Association (COA) Annual Meeting.
Held from December 4 to 8 in Wuhan, Hubei Province, the event is a large-scale international conference attended by healthcare professionals from China and abroad. It serves as a platform for sharing cutting-edge trends and new paradigms among medical specialists, university professors, and medical device professionals.
The COA Annual Meeting contributes significantly to the development of China’s medical industry by offering specialized academic lectures, showcasing the latest technologies and equipment, and fostering collaboration between physicians, researchers, hospitals, and businesses. The conference has been steadily expanding, featuring international orthopedic experts who share their expertise and insights.
At the exhibition, REV-MED showcased its flagship export products, including NovaStem, TriCell, and PRP UNI—kits designed to extract and concentrate key beneficial cells from bone marrow and blood. Its patented Three-Chamber system minimizes manipulation and blocks red blood cells that can trigger inflammation, enabling safe and high-concentration preparation of biologics for a wide range of clinical applications.
A REV-MED representative stated,
“Through our participation in the COA Annual Meeting, we were able to present our technological capabilities to stakeholders from China and abroad. We will continue to strengthen our position as a global leader in regenerative medicine.”
Meanwhile, in 2024, REV-MED has participated in 26 domestic and international academic conferences and exhibitions, actively promoting the excellence of its products.
Reporter Byunghak Lee | lbh@thebigdata.co.kr
Source: BigDataNews